US 11110154
Methods and compositions for treating Huntington's Disease
granted A61KA61K38/00A61K38/1709
Quick answer
US patent 11110154 (Methods and compositions for treating Huntington's Disease) held by Sangamo Therapeutics, Inc. expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00, A61K38/1709, A61K38/18, A61K38/465